Skip to main content
SpringerLink
Log in

Drug effects on the sinus node a clinical perspective

  • Arrhythmias
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Summary

The direct and indirect effects of drugs on the sinoatrial (SA) node are described in relation to basic cellular mechanisms and clinical applications. The effects of the different classes of antiarrhythmic agents are considered in terms of their direct depressant and excitatory actions. Indirect actions, particularly autonomic effects, are also discussed. Clinical aspects of the pharmacologic management of disorders of sinus node function such as the bradycardiatachycardia syndrome, inappropriate sinus tachycardia, sinus bradycardia, and the identification of sinus node dysfunction by drug effects are considered in detail.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Brown HF. Electrophysiology of the sinoatrial node. Physiol Rev 1982; 62:505–530.

    Google Scholar 

  2. Bouman LN, Jongsma HJ. Structure and function of the sino-atrial node: A review. Eur Heart J 1986; 7:94–104.

    Google Scholar 

  3. Yanagihara K, Irisawa H. Inward current activated during hyperpolarisation in the rabbit sinoatrial node cell. Pflugers Arch 1980; 385:11–19.

    Google Scholar 

  4. Hoffman BF, Rosen MR, Wit AL. Electrophysiology and pharmacology of cardiac arrhythmias. VII. Cardiac effects of quinidine and procaine amide B. Am Heart J 1975; 90:117–122.

    Google Scholar 

  5. Goldberg D, Reiffel JA, Davis JC, et al, Electrophysiologic effects of procainamide on sinus function in patients with and without sinus node disease. Am Heart J 1982; 103:75–79.

    Google Scholar 

  6. Lippestad CT, Forfang K. Production of sinus arrest by lignocaine. Br Med J 1971; i:537.

    Google Scholar 

  7. Roos JC, Paalman ACA, Dunning AJ. Electrophysical effects of mexiletine in man. Br Heart J 1976; 38:1262–1271.

    Google Scholar 

  8. Cassagneau B, Calazel J, Bounhoure JP, et al. Electrophysiologic effects of oral encainide, with and without autonomic blockade. In: Levy S, Gerard R, eds. Recent Advances in Cardiac Arrhythmias. London: John Libbey, 1983;373.

    Google Scholar 

  9. Camm AJ. Cardiac electrophysiology of four new antiarrhythmic drugs—encainide, flecainide, lorcainide and tocainide. Eur Heart J 1984; (Suppl E):75–79.

  10. Hellestrand KJ, Nathan AW, Bexton RS, Camm AJ. Response of an abnormal sinus node to intravenous flecainide acetate. Pacing Clin Electrophysiol 1984; 7:436–439.

    Google Scholar 

  11. Strauss HC, Gilbert M, Svenson RH, et al, Electrophysiologic effects of propranolol on sinus node function in patients with sinus node dysfunction. Circulation 1976; 54:452–459.

    Google Scholar 

  12. Narula OS, Vasquez M, Shantha N, Chuquimia R, et al. Effect of propranolol on normal and abnormal sinus node function. In: Bonke FIM, ed. The Sinus Node. Structure, Function and Clinical Relevance. The Hague: Martinus Nijhoff, 1978;112.

    Google Scholar 

  13. Yabek SM, BermanJr W, Dillon T. Electrophysiologic effects of propranolol on sinus node function in children. Am Heart J 1982; 104:612–616.

    Google Scholar 

  14. Strauss HC, Bigger JTJr. Electrophysiologic properties of the rabbit sinoatrial perinodal fibers. Circ Res 1972; 31:490–506.

    Google Scholar 

  15. Rizzon P, di Biase M, Chiddo A, et al. Electrophysiological properties of intravenous metoprolol in man. Br Heart J 1978; 40:650–655.

    Google Scholar 

  16. Greenspan AM, Spielman SR, Horowitz LN, et al. Electrophysiology of esmolol. Am J Cardiol 1985; 56:19F-24F.

    Google Scholar 

  17. Touboul P, Atallah G, Gressard A, Kirkorian G. Effects of amiodarone on sinus node in man. Br Heart J 1979; 42:573–578.

    Google Scholar 

  18. McGovern B, Garan H, Kelly E, Ruskin JN. Adverse reactions during treatment with amiodarone hydrochloride. Br Med J 1983; 287:175–180.

    Google Scholar 

  19. Antman EM, Stone Ph, Muller JE, Braunwald E. Calcium channel blocking agents in the treatment of cardiovascular disorders. Part I: Basic and clinical electrophysiological effects. Ann Intern Med 1980; 93:875–885.

    Google Scholar 

  20. Henry PD. Calcium ion (Ca++) antagonists: Mechanisms of action and clinical applications. Pract Cardiol 1979; 5:145–156.

    Google Scholar 

  21. Kass RS, Tsien RW. Multiple effects of calcium antagonists on plateau currents in cardiac Purkinje fibers. J Gen Physiol 1975; 66:169–192.

    Google Scholar 

  22. Kawai C, Konishi T, Matsuyama E, Okazaki H. Comparative effects of three calcium antagonists, diltiazem, verapamil and nifedipine, on the sinoatrial and atrioventricular nodes. Circulation 1981; 63:1035–1042.

    Google Scholar 

  23. Breithardt G, Seipel L, Wiebringhaus E. Dual effect of verapamil on sinus node function in man. In Bonke FIM, ed. The Sinus Node. Structure, Function and Clinical Relevance. The Hague: Martinus Nijhoff, 1978;129.

    Google Scholar 

  24. Padeletti L, Franchi F, Brat A, et al. The cardiac electrophysiologic effects of nifedipine. Int J Clin Pharmacol Biopharmacol 1979; 17:290–293.

    Google Scholar 

  25. Briethardt G, Seipel L, Wiebringhaus E, Loogen F. Effect of verapamil on sinus node in patients with normal and abnormal sinus node function. Circulation 1976; 54(Suppl II):19.

    Google Scholar 

  26. Imamura T, Koiwaya Y, Nakamura M. Sinoatrial block induced by oral diltiazem. Clin Cardiol 1986; 9:33–34.

    Google Scholar 

  27. Villani GQ, del Giudice S, Arruzzoli S, Dieci G. Sinoatrial block after oral administration of nifedipine. Minerva Cardioangiol 1985; 33:557–559.

    Google Scholar 

  28. Winsor T, Bleifer K, Cole S, et al. A double-blind, double cross-over trial of prenylamine in angina pectoris. Am Heart J 1971; 82:43–54.

    Google Scholar 

  29. Simoons ML, Hugenholtz PG. Haemodynamic effects of alinidine, a specific sinus node inhibitor, in patients with unstable angina or myocardial infarction. Eur Heart J 1984; 5:227–232.

    Google Scholar 

  30. Haberl R, Steinbeck G. Chronotropic action of alinidine on the isolated sinus node of the rabbit heart. Eur Hart J 1985; 6:730–736.

    Google Scholar 

  31. Millar JS, Vaughan Williams EM. Pacemaker selectivity: Influence on rabbit atria of ionic environment and of alinidine, a possible anion antagonist. Cardiovasc Res 1981; 15:335–350.

    Google Scholar 

  32. Millar JS, Vaughan Williams EM. Anion antagonism—a fifth class of antiarrhythmic action? Lancet 1981; i:1291–1293.

    Google Scholar 

  33. Nawrath H, Jochem G. On the mechanisms of the negative inotropic action of adenosine in the guinea pig heart. Naunyn-Schmiedebergs Arch Pharmacol 1982; 319:R37.

  34. Belardinelli L, Rubio R, Berne RM. Blockade of Ca2+ dependent rat atrial slow action potentials by adenosine and lanthanum. Pflugers Arch 1979; 380:19–27.

    Google Scholar 

  35. DiMarco JP, Sellers TD, Berne RM, et al. Adenosine: Electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia. Circulation 1983; 68:1254–1263.

    Google Scholar 

  36. Berne RM, DiMarco JP, Belardinelli L. Dromotropic effects of adenosine and adenosine antagonists in the treatment of cardiac arrhythmias involving the atrioventricular node. Circulation 1984; 69:1195–1197.

    Google Scholar 

  37. Watt AH. Hypothesis: Sick sinus syndrome: An adenosine-mediated disease. Lancet 1985; i:786–788.

    Google Scholar 

  38. Feleke E, Rydan L, Smedgard P, Westerling S. Prenalterol in symptomatic sinus node dysfunction. Am Heart J 1984; 108:185–187.

    Google Scholar 

  39. Befeler B, CastellanosJr A, Wells DE, et al. Electrophysiologic effects of the antiarrhythmic agent disopyramide phosphate. Am J Cardiol 1975; 35:282–287.

    Google Scholar 

  40. Seipel L, Breithardt G. Sinus node recovery time after disopyramide phosphate. Am J Cardiol 1976; 37:1118.

    Google Scholar 

  41. Mason JW, Winkle RA, Rider AK, et al. The electrophysiologic effects of quinidine in the transplanted human heart. J Clin Invest 1977; 59:481–489.

    Google Scholar 

  42. Chai CY, Wang HH, Hoffman BF, Wan SC. Mechanism of bradycardia induced by digitalis substances. Am J Physiol 1967; 212:26–34.

    Google Scholar 

  43. Reiffel JA, BiggerJr JT, Cramer M. Effects of digoxin on sinus nodal function before and after vagal blockade in patients with sinus nodal dysfunction. Am J Cardiol 1979; 43:983–989.

    Google Scholar 

  44. Goodman DJ, Rossen RM, Ingham R, Rider AK, Harrison DC. Sinus node function in the denervated human heart: Effect of digitalis. Br Heart J 1975; 37:612–618.

    Google Scholar 

  45. Alboni P, Shantha N, Filippi L, et al. Clinical effects of digoxin on sinus node and atrioventricular node function after pharmacologic autonomic blockade. Am Heart J 1984; 108:1255–1261.

    Google Scholar 

  46. Vera Z, Miller RR, McMillin D, Mason DT. Effects of digitalis on sinus nodal function in patients with sick sinus syndrome. Am J Cardiol 1978; 41:318–323.

    Google Scholar 

  47. Montalescot G, Levy Y, Hatt PY. Serious sinus node dysfunction caused by theraputic doses of lithium. Int J Cardiol 1984; 5:94–96.

    Google Scholar 

  48. Palileo EV, Coelho A, Westveer D, et al. Persistent sinus node dysfunction secondary to lithium therapy. Am Heart J 1983; 104:1443–1444.

    Google Scholar 

  49. Reding P, Devroede C, Barbier P. Bradycardia after cimetidine. Lancet 1977; ii:1227.

    Google Scholar 

  50. Linberger ASIII, Sprague DH, Battaglini JW. Sinus arrest associated with cimetidine. Anesth Analg 1985; 64:554–556.

    Google Scholar 

  51. Garratt C, Camm AJ. Histamine, histamine antagonists, and the human heart. Clin Prog Electrophysiol Pacing 1985; 3:419–425.

    Google Scholar 

  52. Engel TR, Luck JC. Histamine2 receptor antagonism by cimetidine and sinus node function. N Eng J Med 1979; 301:591–592.

    Google Scholar 

  53. Cayley ACD, MacPhearson A, Wedgwood J. Sinus bradycardia following treatment with hydergine for cerebrovascular insufficiency. Br Med J 1975; iv:384–385.

    Google Scholar 

  54. Flowers NC, Hand RC, Horan LG. Concentrations of fluoroalkanes associated with cardiac conduction system toxicity. Arch Environ Health 1975; 30:353–360.

    Google Scholar 

  55. Viersma JW, van den Berg MP, van Gilst WH, Lie KI. Intrinsic sympathomimetic activity (ISA) of pindolol in patients with sinus node function. Eur Heart J 1986; 7:42–46.

    Google Scholar 

  56. Tseu FI, Morley CA, Mackintosh Af. Oral xamoterol in patients with sinoatrial disease. Br Heart J 1986; 56:469–472.

    Google Scholar 

  57. Swedberg K, Hjalmarson A, Waagstein F, Wallentin I. Beneficial effects of long-term beta blockade in congestive cardiomyopathy. Br Heart J 1980; 44:117–133.

    Google Scholar 

  58. Currie PJ, Kelly MJ, McKenzie A, et al. Oral beta-adrenergic blockade with metoprolol in chronic severe dilated cardiomyopathy. J Am Coll Cardiol 1984; 3:203–209.

    Google Scholar 

  59. Vaisrub S. Da Costa syndrome revisited. JAMA 1975; 232:164.

    Google Scholar 

  60. Editorial: The sick sinus syndrome. Br Med J 1973; ii:677–678.

  61. Benditt DG, BensonJr DW, Kreitt J, et al. Electrophysiologic effects of theophylline in young patients with recurrent symptomatic bradyarrhythmias. Am J Cardiol 1983; 52:1223–1229.

    Google Scholar 

  62. Belardinelli L, Mattos EC, Berne RM. Evidence for adenosine mediation of atriovascular block in th ischemic canine myocardium. J Clin Invest 1981; 68:195–205.

    Google Scholar 

  63. Engel TR, Leddy C, del Gonzalez A, et al. Electrophysiologic effects of hydralazine on sinoartial function in patients with sick sinus node syndrome. Am J Cardiol 1978; 41:763–769.

    Google Scholar 

  64. Gupta KP, Bhargava KP. Mechanism of tachycardia induced by intracerebroventricular injection of hydralazine (1-hydrazino-phthalazine). Arch Int Pharmacodyn Ther 1965; 155:84–89.

    Google Scholar 

  65. Franciosa JA, Pierpoint G, Cohn JN. Hemodynamic improvement after oral hydralazine in left ventricular failure. A comparison with nitroprusside infusion in 16 patients. Ann Intern Med 1977; 86:388–393.

    Google Scholar 

  66. Mond HG. The bradyarrhythmias: Current indications for permanent pacing (Part I). Pacing Clin Electrophysiol 1981; 4:432–442.

    Google Scholar 

  67. Shaw DB, Hocknell JM. Natural history of sinoatrial disorders. Clin Prog Pacing Electrophysiol 1983; 1:335–348.

    Google Scholar 

  68. Raviele A, Di Pede F, Zanocco A, et al. Valore predittivo del test all'ajmalina nelle disfunzioni del nodo del seno. G Ital Cardiol 1985; 15:751–760.

    Google Scholar 

  69. Vardas P, Travill C, Bayliss J, et al. Intravenous administration of flecainide as a stress test for syncopal patients with normal electrophysiology. Pacing Clin Electrophysiol 1987; 10:758.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiological Sciences, St George's Hospital Medical School, London, England

    Nicholas J. Linker & A. John Camm

Authors
  1. Nicholas J. Linker
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. John Camm
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Linker, N.J., Camm, A.J. Drug effects on the sinus node a clinical perspective. Cardiovasc Drug Ther 2, 165–170 (1988). https://doi.org/10.1007/BF00051231

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00051231

Key Words

Search

Navigation